Metrics as of 10/13/2026, 06:54 PM (Berlin time), refresh in progress.
Tectonic Therapeutic Stock
Tectonic Therapeutic, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Alise S. Reicin
- Employees
- 60
- Market cap
- $402 M
- IPO
- 21/06/2018
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology…
Tectonic Therapeutic stock: price history
1D
-4.7%
1W
-4.9%
1M
-26.6%
6M
-28.8%
YTD
+2.2%
1Y
+32.4%
2Y
-32.0%
5Y
-67.9%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~9% weaker price swings than usual
Ask the agents about Tectonic Therapeutic
Analyst assessment of Tectonic Therapeutic
PRICE TARGET LOW
US$26.00
CONSENSUS
US$62.33
MEDIAN
US$80.00
PRICE TARGET HIGH
US$81.00
1
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 07/08/2026
Tectonic Therapeutic stock metrics
P/E
-4.66
P/B
1.81
EV/EBITDA
-2.14
RETURN ON EQUITY
-10.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
50.2%
FLOAT SHARES
9,481,055
AVG. DAILY VOLUME (30D)
225,682
Insider transactions (SEC)
Ruddy Marcella K.
REICIN ALISE
McNamara Peter
McNamara Peter
Schwabish Marc
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Tectonic Therapeutic stock
What does Tectonic Therapeutic do?
Tectonic Therapeutic, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Alise S. Reicin, the company employs around 60 people.
The IPO was on 21/06/2018; the stock trades on NASDAQ under the ticker TECX.
What do analysts say about Tectonic Therapeutic stock?
5 analysts rate the stock, the consensus is Buy (as of 07/08/2026).
The average price target is US$62.33, ranging from US$26.00 to US$81.00, with a median of US$80.00.
This is an external assessment, not a statement by Market Jury.
When does Tectonic Therapeutic report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly -9% stronger than usual.
Does Tectonic Therapeutic pay a dividend?
No, Tectonic Therapeutic currently does not pay a dividend.
Which stocks are comparable to Tectonic Therapeutic?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Tectonic Therapeutic stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tectonic Therapeutic against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.